Restless Legs: What has happened to Dopamine Agonists?

episode

Mayo Clinic Center for Sleep Medicine not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Q+A: The Week Ahead with NAB | 28 Sep 2026 11 min · 27 Sep 2026 · FEAR & GREED | Business News

NPR News: 09-27-2026 1PM EDT 4 min · 27 Sep 2026 · NPR News Now

1PM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

257 2h 13m · 27 Sep 2026 · The Connect- with Johnny Mitchell

Sharp or Square - FINAL NFL WEEK 3 Bets: Patriots-Jaguars, Rams-Broncos and more 33 min · 27 Sep 2026 · The Herd with Colin Cowherd

CM Punk's Effect on the Men's MITB Ladder Match 41 min · 27 Sep 2026 · Busted Open

Report any issue

Source

Recorded01 Apr 2024

Publisherfeed.podbean.com ↗

Handlerec:11639868

Show notes

The last few years have shown a major change in first-line management of restless legs. In this podcast, Dr. Michael Silber discusses why gabapentinoids are now first-line therapy rather than dopamine agonists, how they are used, and whether there is any role still for the dopaminergic drugs.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in